These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Visceral leishmaniasis in HIV-infected patients with non-detectable HIV-1 viral load after highly active antiretroviral therapy. Jiménez-Expósito MJ; Alonso-Villaverde C; Sardà P; Masana L AIDS; 1999 Jan; 13(1):152-3. PubMed ID: 10207569 [No Abstract] [Full Text] [Related]
9. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651 [TBL] [Abstract][Full Text] [Related]
10. 2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy. Elliot B; Aromin I; Gold R; Flanigan T; Mileno M Lancet; 1997 Mar; 349(9055):850. PubMed ID: 9121266 [No Abstract] [Full Text] [Related]
11. Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy. Martínez E; Miró JM; González J; Mallolas J; Gatell JM AIDS; 1999 Jan; 13(1):147-8. PubMed ID: 10207565 [No Abstract] [Full Text] [Related]
12. State of the art: antiretroviral and prophylactic treatments in HIV/AIDS. Porche DJ Nurs Clin North Am; 1999 Mar; 34(1):95-112. PubMed ID: 9922281 [TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leucoencephalopathy in AIDS: treatment with cytosine arabinoside. Guarino M; D'Alessandro R; Rinaldi R; Stracciari A; Pazzaglia P; Costigliola P; Marinacci G; Chiodo F; Di Giandomenico G; Cancellieri C AIDS; 1995 Jul; 9(7):819-20. PubMed ID: 7546435 [No Abstract] [Full Text] [Related]
14. [Diagnosis and treatment of ocular viral infections in AIDS patients]. Guex-Crosier Y Rev Med Suisse Romande; 1998 Nov; 118(11):941-7. PubMed ID: 9865123 [TBL] [Abstract][Full Text] [Related]
15. Favourable outcome of progressive multifocal leukoencephalopathy with mefloquine treatment in combination with antiretroviral therapy in an HIV-infected patient. Adachi E; Koibuchi T; Imai K; Kikuchi T; Koga M; Nakamura H; Miura T; Iwamoto A; Fujii T Int J STD AIDS; 2012 Aug; 23(8):603-5. PubMed ID: 22930304 [TBL] [Abstract][Full Text] [Related]
16. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients. Revankar SG; Sanche SE; Dib OP; Caceres M; Patterson TF AIDS; 1998 Dec; 12(18):2511-3. PubMed ID: 9875598 [No Abstract] [Full Text] [Related]
17. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739 [TBL] [Abstract][Full Text] [Related]
18. Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy. Portilla J; Boix V; Román F; Reus S; Merino E J Infect; 2000 Sep; 41(2):182-4. PubMed ID: 11023768 [TBL] [Abstract][Full Text] [Related]
19. Resolution of chronic parvovirus b19-induced anemia, by use of highly active antiretroviral therapy, in a patient with acquired immunodeficiency syndrome. Ware AJ; Moore T Clin Infect Dis; 2001 Apr; 32(7):E122-3. PubMed ID: 11264051 [TBL] [Abstract][Full Text] [Related]
20. Are we winning the battle against the human immunodeficiency virus. Sullivan AK; Nelson MR Br J Hosp Med; 1997 Nov 19-Dec 9; 58(10):486-8. PubMed ID: 10193449 [No Abstract] [Full Text] [Related] [Next] [New Search]